amifampridine has been researched along with Carcinoma, Small Cell in 12 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (75.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Titulaer, MJ | 1 |
Lang, B | 1 |
Verschuuren, JJ | 1 |
Newsom-Davis, J | 3 |
Morata, C | 1 |
Alfaro, A | 1 |
Chumillas, MJ | 1 |
Montalar, J | 1 |
Casanova, B | 1 |
VĂlchez, JJ | 1 |
Rubio, P | 1 |
Tim, RW | 2 |
Massey, JM | 2 |
Sanders, DB | 2 |
Oh, SJ | 1 |
Kim, DS | 1 |
Kwon, KH | 1 |
Tseng, A | 1 |
Mussell, H | 1 |
Claussen, GC | 1 |
Arbusow, V | 1 |
Voltz, RD | 1 |
Strupp, M | 1 |
Schulz, P | 1 |
Seneviratne, U | 1 |
de Silva, R | 1 |
Chalk, CH | 1 |
Murray, NM | 1 |
O'Neill, JH | 1 |
Spiro, SG | 1 |
Manji, H | 1 |
Schwartz, MS | 1 |
McKeran, RO | 1 |
3 reviews available for amifampridine and Carcinoma, Small Cell
Article | Year |
---|---|
Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Topics: 4-Aminopyridine; Amifampridine; Autoantibodies; Calcium Channels; Carcinoma, Small Cell; Humans; Lam | 2011 |
Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Amifampridine; Autoantibodies; Autoantigens; Autoimmune Diseases of the Nervous Sys | 2004 |
Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Amifampridine; Anti-Inflammatory Agents; Autoantibodies; Calcium Channels; Carcinom | 1999 |
9 other studies available for amifampridine and Carcinoma, Small Cell
Article | Year |
---|---|
[Lambert-Eaton myasthenic syndrome: response to treatment with 3,4-diaminopyridine].
Topics: 4-Aminopyridine; Aged; Amifampridine; Carcinoma, Small Cell; Humans; Lambert-Eaton Myasthenic Syndro | 1995 |
[The treatment of the Eaton-Lambert myasthenic syndrome with 3,4-diaminopyridine].
Topics: 4-Aminopyridine; Amifampridine; Carcinoma, Small Cell; Drug Evaluation; Humans; Lambert-Eaton Myasth | 1993 |
A treatment algorithm for Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Algorithms; Amifampridine; Azathioprine; Carcinoma, Small Cell; Clinical Protocols; | 1998 |
Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients.
Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Amifampridine; Autoantibodies; Carcinoma, Small Cell; Chil | 1998 |
Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Adult; Aged; Amifampridine; Carcinoma, Small Cell; Female; Guanidine; Humans; Lambe | 1998 |
Successful treatment of peripheral paraneoplastic neurological syndromes in small cell cancer.
Topics: 4-Aminopyridine; Aged; Amifampridine; Antineoplastic Agents; Carcinoma, Small Cell; Female; Humans; | 1998 |
Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment.
Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Aged, 80 and over; Amifampridine; Carcinoma, Small Cell; C | 2000 |
Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma.
Topics: 4-Aminopyridine; Action Potentials; Adult; Aged; Amifampridine; Carcinoma, Small Cell; Combined Moda | 1990 |
Lambert Eaton syndrome: autonomic neuropathy and inappropriate antidiuretic hormone secretion in a patient with small cell carcinoma of the lung.
Topics: 4-Aminopyridine; Aged; Amifampridine; Carcinoma, Small Cell; Humans; Inappropriate ADH Syndrome; Lam | 1990 |